Sidabraite, A.; Mosert, P.L.; Ahmed, U.; Jones, S.K.; Gulla, A.
Advancing Cholangiocarcinoma Diagnosis: The Role of Liquid Biopsy and CRISPR/Cas Systems in Biomarker Detection. Cancers 2025, 17, 2155.
https://doi.org/10.3390/cancers17132155
AMA Style
Sidabraite A, Mosert PL, Ahmed U, Jones SK, Gulla A.
Advancing Cholangiocarcinoma Diagnosis: The Role of Liquid Biopsy and CRISPR/Cas Systems in Biomarker Detection. Cancers. 2025; 17(13):2155.
https://doi.org/10.3390/cancers17132155
Chicago/Turabian Style
Sidabraite, Agne, Paula Lucia Mosert, Uzair Ahmed, Stephen Knox Jones, and Aiste Gulla.
2025. "Advancing Cholangiocarcinoma Diagnosis: The Role of Liquid Biopsy and CRISPR/Cas Systems in Biomarker Detection" Cancers 17, no. 13: 2155.
https://doi.org/10.3390/cancers17132155
APA Style
Sidabraite, A., Mosert, P. L., Ahmed, U., Jones, S. K., & Gulla, A.
(2025). Advancing Cholangiocarcinoma Diagnosis: The Role of Liquid Biopsy and CRISPR/Cas Systems in Biomarker Detection. Cancers, 17(13), 2155.
https://doi.org/10.3390/cancers17132155